Surmodics reported $64.46M in Current Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Align Technology ALGN:US USD 2.42B 76.19M
Anika Therapeutics ANIK:US USD 169.55M 1.79M
Arrowhead Research ARWR:US USD 575M 169.7M
Baxter International BAX:US USD 8.01B 201M
Bioscrip BIOS:US USD 994.34M 42.38M
Cryolife CRY:US USD 247.33M 9.34M
Edap Tms EDAP:US EUR 70.85M 4.29M
Edwards Lifesciences EW:US USD 3.1B 418.1M
Haemonetics HAE:US USD 706.31M 9.48M
Heron Therapeutics HRTX:US USD 205.44M 18.37M
Merit Medical Systems MMSI:US USD 529.08M 29.22M
Mesa Laboratories MLAB:US USD 114.18M 2.07M
Nektar Therapeutics NKTR:US USD 545.97M 53.52M
Stryker SYK:US USD 10.28B 957M
Surmodics SRDX:US USD 64.46M 6.88M